Syn 1001
Latest Information Update: 16 Jul 2016
At a glance
- Originator Synt:em
- Class
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Pain in France (IV)
- 11 Jul 2003 Phase-I clinical trials in Pain in France (IV)